 utility levels human pancreatic polypeptide marker islet cell tumors measurement plasma levels human pancreatic polypeptide hPP useful existence pancreatic islet cell neoplasms patients familial multiple endocrine neoplasia type FMEN-I possible presence metastatic disease patients islet cell tumors studies prospective small numbers patients study plasma samples patients biopsy-proved islet cell tumors hPP radioimmunoassay age-matched control subjects patients FMEN-I islet cell tumors plasma hPP levels surgery resection islet cell tumors patients surgery levels Fifteen patients cell tumors insulinomas gastrinomas none patients hPP levels surgery patients FMEN-I metastatic islet cell tumors liver advanced disease hPP levels surgery patients underwent resection gross disease patients elevated preoperative levels normal postoperative hPP levels results basal plasma levels hPP useful hPP levels presence islet cell tumors patients FMEN-I patients tumors plasma levels elevated values levels resection tumor Plasma levels hPP utility patients islet cell tumors limited utility presence metastatic islet cell tumors liver